

Our purpose is clear: delivering life-changing therapies as efficiently and quickly as possible to help people living with rare diseases and common diseases that have a genetic component.
At Dicerna, we create medicines that selectively silence the genes that cause disease using RNA interference, or RNAi. We are leaders in RNAi, harnessing the potential of this powerful and complex process to create medicines that can enhance the health and extend the lives of patients with rare diseases and common diseases that have a genetic component.
2 employees at Dicerna Pharmaceuticals have reviewed Dicerna Pharmaceuticals across various culture dimensions, providing their opinions on items ranging from executive ratings to the pace at work. The latest review was months ago.
Dicerna Pharmaceuticals is focused on the discovery and development of innovative treatments for rare inherited diseases.










They made a quick decision
Get to still work from home
base pay is very high
Less repetitive meetings, set goals
Buyout has been a nightmare, no direction or leadership. Projects have come to a grinding hault

Tell Dicerna Pharmaceuticals you're interested in working at the company, while keeping your personal identity anonymous. Comparably will give Dicerna Pharmaceuticals the opportunity to hire you. When there's a job opening that's a fit we'll make the match happen.
In 2019, Dicerna Pharmaceuticals applied for 1 H1B visas.
H1B Applications Outcome
This data was calculated using publicly sourced data from OFLC Performance Data
| 50% | Promoters |
|---|---|
| 0% | Passives |
| 50% | Detractors |





Send them an invite to rate the company culture.